Clinical Trials Logo

Clinical Trial Summary

This study will use Magnetic Resonance Imaging (MRI) techniques to evaluate changes in fluid volume in the lower legs of diabetic patients who add either pioglitazone or placebo to their current diabetic regimen.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00269061
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 1
Start date January 2006

See also
  Status Clinical Trial Phase
Completed NCT00231387 - Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus Phase 3
Completed NCT00318656 - 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes Phase 4
Terminated NCT01582282 - Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects Phase 4
Not yet recruiting NCT06401733 - Intensive Aerobic and Resistance Exercise Program (IAREP) N/A
Completed NCT02722499 - Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST) N/A
Completed NCT01472328 - Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes N/A
Completed NCT00291356 - GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients Phase 2
Completed NCT00825383 - Effect of Dietary Fiber on Glucose & Lipids in Non Insulin Dependent Diabetes Mellitus (NIDDM) N/A
Completed NCT00359112 - AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes Phase 3
Completed NCT00156897 - Efficacy and Safety of ATL-962 in Obese Diabetics Phase 2